These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 7077931

  • 1. [Pharmacokinetic characteristics of trimecaine compared to lidocaine in myocardial infarct patients].
    Piotrovskiĭ VK, Smirnova EB, Riabokon' OS, Metelitsa VI.
    Kardiologiia; 1982 Apr; 22(4):62-5. PubMed ID: 7077931
    [Abstract] [Full Text] [Related]

  • 2. [Comparative clinical study of trimecaine and lidocaine as anti-arrhythmia agents in myocardial infarct].
    Riabokon' OS, Piotrovskiĭ VK, Smirnova EB, Metelitsa VI, Mazur NA.
    Kardiologiia; 1980 Oct; 20(10):40-2. PubMed ID: 6160280
    [Abstract] [Full Text] [Related]

  • 3. [Comparative clinical study of the effectiveness of the new anti-arrhythmia agents, trimecaine and pyrromecaine].
    Pavlova TS, Riabokon' OS, Ivanova LA, Sumarokov AB.
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983 Oct; 6(2):67-72. PubMed ID: 6196040
    [Abstract] [Full Text] [Related]

  • 4. [Prevention of ventricular fibrillation using lidocaine in the acute period of a myocardial infarct].
    Mazur NA, Riabokon' OS, Banshchikov GT.
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982 Oct; 5(2):59-64. PubMed ID: 6182894
    [Abstract] [Full Text] [Related]

  • 5. [Therapeutic efficacy of trimecaine in cardiac rhythm disorders and ways of improving it].
    Tatarchenko IP, Oleĭnikov VE, Zhivotovskaia GG, Malinovskaia LI.
    Kardiologiia; 1984 Dec; 24(12):51-5. PubMed ID: 6084095
    [Abstract] [Full Text] [Related]

  • 6. [Lidocaine elimination and dose adjustment in acute heart infarct and heart insufficiency].
    Kettner W, Banditt P, Walther H.
    Z Gesamte Inn Med; 1984 Jul 15; 39(14):335-42. PubMed ID: 6485432
    [Abstract] [Full Text] [Related]

  • 7. [Comparative characteristics of the antiarrhythmic activity of lidocaine, trimecaine and pyromecaine].
    Orlov VM, Ivashchuk AG, Iartsev SS, Meshcheriakova NK, Tkhu FT.
    Sov Med; 1984 Jul 15; (3):82-4. PubMed ID: 6719244
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical pharmacokinetics and hemodynamics of ethacizin in the acute period of myocardial infarct].
    Beloborodov VL, Klimov AV, Tiukavkina NA, Kaverina NV, Pokazeeva ET.
    Farmakol Toksikol; 1986 Jul 15; 49(5):32-6. PubMed ID: 3770172
    [Abstract] [Full Text] [Related]

  • 9. [The antiarrhythmic activity of the trimecain ammonium derivative in myocardial ischemia].
    Kostin IaV, Blinov DS, Moiseeva IIa.
    Eksp Klin Farmakol; 2003 Jul 15; 66(3):29-31. PubMed ID: 12924229
    [Abstract] [Full Text] [Related]

  • 10. [Lidocaine pharmacokinetics and substantiation of the new method of its administration in myocardial infarct].
    Piotrovskiĭ VK, Smirnova EB, Riabokon' OS, Mazur NA, Metelitsa VI.
    Kardiologiia; 1979 Jul 15; 19(7):23-7. PubMed ID: 470315
    [Abstract] [Full Text] [Related]

  • 11. [Pharmacokinetics of propranolol, phenytoin and lidocaine in hypercholesterolemic rabbits].
    Vinçon G, Ploux D, Pehourcq F, Albin H.
    J Pharmacol; 1983 Jul 15; 14(1):47-55. PubMed ID: 6834851
    [Abstract] [Full Text] [Related]

  • 12. [Transplacental transport of trimecaine during the management of labor under prolonged peridural anesthesia].
    Babaev VA.
    Akush Ginekol (Mosk); 1980 Dec 15; (12):16-9. PubMed ID: 7212192
    [No Abstract] [Full Text] [Related]

  • 13. [Possibility of using trimecaine for the treatment of cardiac rhythm disorders in myocardial infarct].
    Poliskiĭ NM, Berger EI, Kotliarskaia LA, Voskoboĭnik LE, Kisel' SS.
    Kardiologiia; 1979 Jul 15; 19(7):59-62. PubMed ID: 89217
    [Abstract] [Full Text] [Related]

  • 14. [Hemodynamic effect of mesocaine and ajmaline in acute myocardial infarct].
    Vítovec J, Chaloupka V.
    Vnitr Lek; 1979 Jul 15; 25(7):641-5. PubMed ID: 494498
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical significance of the determination of lidocaine and anti-arrhythmic drugs in acute myocardial infarct].
    Matta F, De Marchi M, Pecchio F, Bevilacqua R, Aillon A, Piccinino C, Riva L, Alvino A, Angelino PF.
    Minerva Cardioangiol; 1981 Apr 15; 29(4):131-6. PubMed ID: 7242944
    [No Abstract] [Full Text] [Related]

  • 16. [Mesocaine levels in plasma after intramuscular and intravenous administration].
    Skalický J, Kubelková J, Jadrný L, Melichar J.
    Vnitr Lek; 1981 Sep 15; 27(9):838-44. PubMed ID: 7293028
    [No Abstract] [Full Text] [Related]

  • 17. Dosage regimens of antiarrhythmics. 1. Pharmacokinetic properties.
    Levy RH, Smith GH.
    Am J Hosp Pharm; 1973 May 15; 30(5):398-404. PubMed ID: 4704419
    [No Abstract] [Full Text] [Related]

  • 18. [Lidocaine pharmacokinetics when administered intramuscularly].
    Piotrovskiĭ VK, Smirnova EB, Riabokon' OS, Metelitsa VI.
    Farmakol Toksikol; 1980 May 15; 43(4):411-6. PubMed ID: 7439378
    [Abstract] [Full Text] [Related]

  • 19. [Comparative studies of the antiarrhythmic activity of prolonged action quaternary ammonium derivatives of trimecaine (G-104) and lidocaine (QX-572)].
    Kostin IaV, Fillipov AK, Grenader AK, Gendenshteĭn EI, Porotikov VI.
    Farmakol Toksikol; 1987 May 15; 50(6):45-7. PubMed ID: 3436423
    [Abstract] [Full Text] [Related]

  • 20. [Effectiveness of trimecaine, a new anti-arrhythmia agent].
    Gendenshteĭn EI, Ganelina IE, Kostin IaV, Kukuĭ LM, Tsybusov AP.
    Klin Med (Mosk); 1980 Jun 15; 58(6):47-50. PubMed ID: 7401603
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.